High density oligonucleotide array analysis of interferon-α2a sensitivity and transcriptional response in melanoma cells

British Journal of Cancer

Volumn 85, Issue 1, 2001, Pages 107-114

  Certa, U ^a   Seiler, M ^a   Padovan, E ^b   Spagnoli, G C ^b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

DNA microarrays; Gene expression; IFN sensitivity; Melanoma; Pharmacogenomics

Indexed keywords

ALPHA2A INTERFERON; CYTOKINE; HLA ANTIGEN;

ADJUVANT THERAPY; ARTICLE; CANCER CELL CULTURE; CANCER SURVIVAL; CELL PROLIFERATION; DNA MICROARRAY; DNA TRANSCRIPTION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PATIENT SELECTION; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; CELL DIVISION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INTERFERON ALFA-2A; MELANOMA; MEMBRANE GLYCOPROTEINS; MULTIGENE FAMILY; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEINS; TRANS-ACTIVATION (GENETICS); UP-REGULATION;

EID: 0035816315     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2001.1865     Document Type: Article

References (37)

1. The human HOX gene family
2. Interferon-induced organic mental disorders associated with unsuspected pre-existing neurologic abnormalities
3. cDNA structures and regulation of two interferon-induced human Mx proteins
4. Interferons in melanoma
5. The cDNA sequence encoding human protein kinase C-zeta
6. Catalysis of guanine nucleotide exchange on Ran by the mitotic regulator RCC1
7. The product of the H19 gene may function as an RNA
8. Characterization of the split hand/split foot malformationlocus SHFM1 at 7q21.3-q22.1 and analysis of a candidate gene for its expression during limb development
9. Expression cloning of an interferon-inducible 17-kDa membrane protein implicate in the control of cell growth
10. White blood cell count: A prognostic factor and possible subset indicator of optimal treatment with low dose adjuvant interferon in primary melanoma
11. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays
12. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes
13. Randomised trial of interferon α-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases
14. Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons
15. Sequence of a cDNA coding for human IRF-2
16. The transcriptional program in the response of human fibroblasts to serum
17. The emerging role of cytokines in the treatment of advanced melanoma
18. Adjuvant IFN alpha2 therapy of melanoma
19. High density synthetic oligonucleotide arrays
20. The pattern of cytokine gene expression in freshly excised human metastatic melanoma suggests u state of reversible anergy of tumor-infiltrating lymphocytes
21. Molecular and biochemical characterization of a novel gamma-interferon-inducible protein
22. Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster
23. A high-density probe array sample preparation method using 10-to 100-fold fewer cells
24. Drug target validation and identification of secondary drug target effects using DNA microarrays
25. The human ROX gene genomic structure and mutation analysis in human breast tumors
26. Naturally processed and concealed HLA-A2.1 restricted epitopes from tumor associated antigen tyrosinase-related protein-2
27. Defective Jak-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-α
28. Resistance of melanoma cell lines to interferons correlates with reduction of IFN-induced tyrosine phosphorilation. Induction of the anti-viral state by IFN is prevented by tyrosine kinase inhibitors
29. Identification of a new interferon-alpha-inducible gene (p27) on human chromosome 14q32 and its expression in breast carcinoma
30. Transcripts imaging of the development of human T helper cells using oligonucleotide arrays
31. The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes - A review
32. Peptide specific CTL in tumor-infiltrated lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and tyrosinase genes: A study in an unselected group of HLA-A2, 1-positive patients
33. Genomic organization of the human cathecol O-methyltransferase gene and its expression from two distinct promoters
34. Genomic organization of IF116, an interferon-inducible gene whose expression is associated with human myeloid cell differentiation: Correlation of predicted protein domains with exon organization
35. Clinical toxicity of Interferons
36. Shb is a ubiquitously expressed Src homology 2 protein
37. Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-1SGF3 gamma